Pharmacological advances in the treatment of nonalcoholic fatty liver diseases : focused on global results of randomized controlled trials

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of liver disease globally, and its prevalence is rapidly increasing. Nonalcoholic steatohepatitis (NASH), a progressive form of NAFLD, is characterized by hepatocellular injury, inflammation, and fibrosis. Patients with NASH or severe...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Jihyun, Sohn, Joo Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029953/
https://www.ncbi.nlm.nih.gov/pubmed/36537018
http://dx.doi.org/10.3350/cmh.2022.0437

Ejemplares similares

Ejemplares similares